Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 27 entries
Sorted by: Best Match Show Resources per page
Data on spray-drying processing to optimize the yield of materials sensitive to heat and moisture content.

Data in brief

Magri G, Franzé S, Musazzi UM, Selmin F, Cilurzo F.
PMID: 31372438
Data Brief. 2019 Feb 28;23:103792. doi: 10.1016/j.dib.2019.103792. eCollection 2019 Apr.

Full dataset used to evaluate the spray-drying process parameters on the preparation of a micronized powder made of maltodextrin (MDX) is herein reported. The process parameters (namely, feed flow rate (FFR); inlet temperature (T

Cite
Magri G, Franzé S, Musazzi UM, et al. Data on spray-drying processing to optimize the yield of materials sensitive to heat and moisture content. Data Brief. 2019;23:103792doi: 10.1016/j.dib.2019.103792.
Magri, G., Franzé, S., Musazzi, U. M., Selmin, F., & Cilurzo, F. (2019). Data on spray-drying processing to optimize the yield of materials sensitive to heat and moisture content. Data in brief, 23103792. https://doi.org/10.1016/j.dib.2019.103792
Magri, Giulia, et al. "Data on spray-drying processing to optimize the yield of materials sensitive to heat and moisture content." Data in brief vol. 23 (2019): 103792. doi: https://doi.org/10.1016/j.dib.2019.103792
Magri G, Franzé S, Musazzi UM, Selmin F, Cilurzo F. Data on spray-drying processing to optimize the yield of materials sensitive to heat and moisture content. Data Brief. 2019 Feb 28;23:103792. doi: 10.1016/j.dib.2019.103792. eCollection 2019 Apr. PMID: 31372438; PMCID: PMC6660546.
Copy Download .nbib Format: NLM
Simulation data for an estimation of the maximum theoretical value and confidence interval for the correlation coefficient.

Data in brief

Rocco P, Cilurzo F, Minghetti P, Vistoli G, Pedretti A.
PMID: 28795106
Data Brief. 2017 Jul 23;14:291-294. doi: 10.1016/j.dib.2017.07.045. eCollection 2017 Oct.

The data presented in this article are related to the article titled "Molecular Dynamics as a tool for in silico screening of skin permeability" (Rocco et al., 2017) [1]. Knowledge of the confidence interval and maximum theoretical value of...

Cite
Rocco P, Cilurzo F, Minghetti P, et al. Simulation data for an estimation of the maximum theoretical value and confidence interval for the correlation coefficient. Data Brief. 2017;14:291-294doi: 10.1016/j.dib.2017.07.045.
Rocco, P., Cilurzo, F., Minghetti, P., Vistoli, G., & Pedretti, A. (2017). Simulation data for an estimation of the maximum theoretical value and confidence interval for the correlation coefficient. Data in brief, 14291-294. https://doi.org/10.1016/j.dib.2017.07.045
Rocco, Paolo, et al. "Simulation data for an estimation of the maximum theoretical value and confidence interval for the correlation coefficient." Data in brief vol. 14 (2017): 291-294. doi: https://doi.org/10.1016/j.dib.2017.07.045
Rocco P, Cilurzo F, Minghetti P, Vistoli G, Pedretti A. Simulation data for an estimation of the maximum theoretical value and confidence interval for the correlation coefficient. Data Brief. 2017 Jul 23;14:291-294. doi: 10.1016/j.dib.2017.07.045. eCollection 2017 Oct. PMID: 28795106; PMCID: PMC5540710.
Copy Download .nbib Format: NLM
Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging.

Pharmaceutics

Franzé S, Selmin F, Samaritani E, Minghetti P, Cilurzo F.
PMID: 30154315
Pharmaceutics. 2018 Aug 28;10(3). doi: 10.3390/pharmaceutics10030139.

Nowadays, the freeze-drying of liposome dispersions is still necessary to provide a solid dosage form intended for different routes of administration (i.e., parenteral, oral, nasal and/or pulmonary). However, after decades of studies the optimization of process conditions remains still...

Cite
Franzé S, Selmin F, Samaritani E, et al. Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging. Pharmaceutics. 2018;10(3)doi: 10.3390/pharmaceutics10030139.
Franzé, S., Selmin, F., Samaritani, E., Minghetti, P., & Cilurzo, F. (2018). Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging. Pharmaceutics, 10(3), . https://doi.org/10.3390/pharmaceutics10030139
Franzé, Silvia, et al. "Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging." Pharmaceutics vol. 10,3 (2018). doi: https://doi.org/10.3390/pharmaceutics10030139
Franzé S, Selmin F, Samaritani E, Minghetti P, Cilurzo F. Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging. Pharmaceutics. 2018 Aug 28;10(3). doi: 10.3390/pharmaceutics10030139. PMID: 30154315; PMCID: PMC6161153.
Copy Download .nbib Format: NLM
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Scicchitano F, Giofrè C, Palleria C, Mazzitello C, Ciriaco M, Gallelli L, Paletta L, Marrazzo G, De Fazio S, Menniti M, Curia R, Arena C, Chimirri S, Patanè M, Esposito S, Cilurzo F, Staltari O, Russo E, De Sarro G.
PMID: 23826016
J Res Med Sci. 2012 Sep;17(9):872-5.

BACKGROUND: Pharmacovigilance assesses the safety profile of drugs. Its main aim is the increase of spontaneous reporting of adverse drug reactions (ADRs). The Italian Drug Agency (AIFA; Agenzia Italiana del Farmaco) is financing several projects to the aim of...

Cite
Scicchitano F, Giofrè C, Palleria C, et al. Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci. 2012;17(9):872-5
Scicchitano, F., Giofrè, C., Palleria, C., Mazzitello, C., Ciriaco, M., Gallelli, L., Paletta, L., Marrazzo, G., De Fazio, S., Menniti, M., Curia, R., Arena, C., Chimirri, S., Patanè, M., Esposito, S., Cilurzo, F., Staltari, O., Russo, E., & De Sarro, G. (2012). Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 17(9), 872-5.
Scicchitano, Francesca, et al. "Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 17,9 (2012): 872-5.
Scicchitano F, Giofrè C, Palleria C, Mazzitello C, Ciriaco M, Gallelli L, Paletta L, Marrazzo G, De Fazio S, Menniti M, Curia R, Arena C, Chimirri S, Patanè M, Esposito S, Cilurzo F, Staltari O, Russo E, De Sarro G. Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci. 2012 Sep;17(9):872-5. PMID: 23826016; PMCID: PMC3697214.
Copy Download .nbib Format: NLM
Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals.

Materials (Basel, Switzerland)

Paolino D, Tudose A, Celia C, Di Marzio L, Cilurzo F, Mircioiu C.
PMID: 30813650
Materials (Basel). 2019 Feb 26;12(5). doi: 10.3390/ma12050693.

In this study, we investigated the release kinetic of fluorescein from colloidal liquid crystals made from monoglyceride and different non-ionic surfactants. The crystals were physicochemically characterized and the release experiments were carried out under the sink conditions, while mathematical...

Cite
Paolino D, Tudose A, Celia C, et al. Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals. Materials (Basel). 2019;12(5)doi: 10.3390/ma12050693.
Paolino, D., Tudose, A., Celia, C., Di Marzio, L., Cilurzo, F., & Mircioiu, C. (2019). Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals. Materials (Basel, Switzerland), 12(5), . https://doi.org/10.3390/ma12050693
Paolino, Donatella, et al. "Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals." Materials (Basel, Switzerland) vol. 12,5 (2019). doi: https://doi.org/10.3390/ma12050693
Paolino D, Tudose A, Celia C, Di Marzio L, Cilurzo F, Mircioiu C. Mathematical Models as Tools to Predict the Release Kinetic of Fluorescein from Lyotropic Colloidal Liquid Crystals. Materials (Basel). 2019 Feb 26;12(5). doi: 10.3390/ma12050693. PMID: 30813650; PMCID: PMC6427212.
Copy Download .nbib Format: NLM
In Vitro Anticancer Activity of Extracellular Vesicles (EVs) Secreted by Gingival Mesenchymal Stromal Cells Primed with Paclitaxel.

Pharmaceutics

Coccè V, Franzè S, Brini AT, Giannì AB, Pascucci L, Ciusani E, Alessandri G, Farronato G, Cavicchini L, Sordi V, Paroni R, Dei Cas M, Cilurzo F, Pessina A.
PMID: 30717104
Pharmaceutics. 2019 Feb 01;11(2). doi: 10.3390/pharmaceutics11020061.

Interdental papilla are an interesting source of mesenchymal stromal cells (GinPaMSCs), which are easy to isolate and expand in vitro. In our laboratory, GinPaMSCs were isolated, expanded, and characterized by studying their secretome before and after priming with paclitaxel...

Cite
Coccè V, Franzè S, Brini AT, et al. In Vitro Anticancer Activity of Extracellular Vesicles (EVs) Secreted by Gingival Mesenchymal Stromal Cells Primed with Paclitaxel. Pharmaceutics. 2019;11(2)doi: 10.3390/pharmaceutics11020061.
Coccè, V., Franzè, S., Brini, A. T., Giannì, A. B., Pascucci, L., Ciusani, E., Alessandri, G., Farronato, G., Cavicchini, L., Sordi, V., Paroni, R., Dei Cas, M., Cilurzo, F., & Pessina, A. (2019). In Vitro Anticancer Activity of Extracellular Vesicles (EVs) Secreted by Gingival Mesenchymal Stromal Cells Primed with Paclitaxel. Pharmaceutics, 11(2), . https://doi.org/10.3390/pharmaceutics11020061
Coccè, Valentina, et al. "In Vitro Anticancer Activity of Extracellular Vesicles (EVs) Secreted by Gingival Mesenchymal Stromal Cells Primed with Paclitaxel." Pharmaceutics vol. 11,2 (2019). doi: https://doi.org/10.3390/pharmaceutics11020061
Coccè V, Franzè S, Brini AT, Giannì AB, Pascucci L, Ciusani E, Alessandri G, Farronato G, Cavicchini L, Sordi V, Paroni R, Dei Cas M, Cilurzo F, Pessina A. In Vitro Anticancer Activity of Extracellular Vesicles (EVs) Secreted by Gingival Mesenchymal Stromal Cells Primed with Paclitaxel. Pharmaceutics. 2019 Feb 01;11(2). doi: 10.3390/pharmaceutics11020061. PMID: 30717104; PMCID: PMC6409699.
Copy Download .nbib Format: NLM
Trends in the Characterization Methods of Orodispersible Films.

Current drug delivery

Khalid GM, Selmin F, Musazzi UM, Gennari CGM, Minghetti P, Cilurzo F.
PMID: 33305704
Curr Drug Deliv. 2021 Dec 10;18(7):935-946. doi: 10.2174/1567201818999201210212557.

The recent increased interest in orodispersible films (ODF) stems from their ideal potential to circumvent several pharmacotherapy-related problems, such as improved medication compliance and adherence, especially in children, elderly and uncooperative patients. Their administration is well accepted by the...

Cite
Khalid GM, Selmin F, Musazzi UM, et al. Trends in the Characterization Methods of Orodispersible Films. Curr Drug Deliv. 2021;18(7):935-946doi: 10.2174/1567201818999201210212557.
Khalid, G. M., Selmin, F., Musazzi, U. M., Gennari, C. G. M., Minghetti, P., & Cilurzo, F. (2021). Trends in the Characterization Methods of Orodispersible Films. Current drug delivery, 18(7), 935-946. https://doi.org/10.2174/1567201818999201210212557
Khalid, Garba M, et al. "Trends in the Characterization Methods of Orodispersible Films." Current drug delivery vol. 18,7 (2021): 935-946. doi: https://doi.org/10.2174/1567201818999201210212557
Khalid GM, Selmin F, Musazzi UM, Gennari CGM, Minghetti P, Cilurzo F. Trends in the Characterization Methods of Orodispersible Films. Curr Drug Deliv. 2021 Dec 10;18(7):935-946. doi: 10.2174/1567201818999201210212557. PMID: 33305704.
Copy Download .nbib Format: NLM
Data on the stability of darunavir/cobicistat suspension after tablet manipulation.

Data in brief

Zanon D, Manca A, De Nicolò A, D'Avolio A, Musazzi UM, Cilurzo F, Maximova N, Tomasello C, Minghetti P.
PMID: 32292805
Data Brief. 2020 Apr 12;30:105552. doi: 10.1016/j.dib.2020.105552. eCollection 2020 Jun.

The COVID-19 outbreak is now one of the most critical crises to manage for most of the national healthcare systems in the world. In the absence of authorised pharmacological treatments, many antiretrovirals, including darunavir/cobicistat fixed combination, are used off-label...

Cite
Zanon D, Manca A, De Nicolò A, et al. Data on the stability of darunavir/cobicistat suspension after tablet manipulation. Data Brief. 2020;30:105552doi: 10.1016/j.dib.2020.105552.
Zanon, D., Manca, A., De Nicolò, A., D'Avolio, A., Musazzi, U. M., Cilurzo, F., Maximova, N., Tomasello, C., & Minghetti, P. (2020). Data on the stability of darunavir/cobicistat suspension after tablet manipulation. Data in brief, 30105552. https://doi.org/10.1016/j.dib.2020.105552
Zanon, D, et al. "Data on the stability of darunavir/cobicistat suspension after tablet manipulation." Data in brief vol. 30 (2020): 105552. doi: https://doi.org/10.1016/j.dib.2020.105552
Zanon D, Manca A, De Nicolò A, D'Avolio A, Musazzi UM, Cilurzo F, Maximova N, Tomasello C, Minghetti P. Data on the stability of darunavir/cobicistat suspension after tablet manipulation. Data Brief. 2020 Apr 12;30:105552. doi: 10.1016/j.dib.2020.105552. eCollection 2020 Jun. PMID: 32292805; PMCID: PMC7152873.
Copy Download .nbib Format: NLM
[No title available]

Pharmaceutics

Hasa D, Žakelj S, Grabnar I, Cilurzo F, Dall'Acqua S, Riva A, Perissutti B, Voinovich D.
PMID: 33207557
Pharmaceutics. 2020 Nov 16;12(11). doi: 10.3390/pharmaceutics12111096.

Dodeca-2

Cite
Hasa D, Žakelj S, Grabnar I, et al. . Pharmaceutics. 2020;12(11)doi: 10.3390/pharmaceutics12111096.
Hasa, D., Žakelj, S., Grabnar, I., Cilurzo, F., Dall'Acqua, S., Riva, A., Perissutti, B., & Voinovich, D. (2020). . Pharmaceutics, 12(11), . https://doi.org/10.3390/pharmaceutics12111096
Hasa, Dritan, et al. "." Pharmaceutics vol. 12,11 (2020). doi: https://doi.org/10.3390/pharmaceutics12111096
Hasa D, Žakelj S, Grabnar I, Cilurzo F, Dall'Acqua S, Riva A, Perissutti B, Voinovich D. . Pharmaceutics. 2020 Nov 16;12(11). doi: 10.3390/pharmaceutics12111096. PMID: 33207557; PMCID: PMC7697022.
Copy Download .nbib Format: NLM
Preserving the Integrity of Liposomes Prepared by Ethanol Injection upon Freeze-Drying: Insights from Combined Molecular Dynamics Simulations and Experimental Data.

Pharmaceutics

Franzè S, Selmin F, Rocco P, Colombo G, Casiraghi A, Cilurzo F.
PMID: 32526935
Pharmaceutics. 2020 Jun 09;12(6). doi: 10.3390/pharmaceutics12060530.

The freeze-drying of complex formulations, such as liposomes, is challenging, particularly if dispersions contain residual organic solvents. This work aimed to investigate the effects of possible protectants, namely sucrose, trehalose and/or poly(vinyl pyrrolidone) (PVP), on the main features of...

Cite
Franzè S, Selmin F, Rocco P, et al. Preserving the Integrity of Liposomes Prepared by Ethanol Injection upon Freeze-Drying: Insights from Combined Molecular Dynamics Simulations and Experimental Data. Pharmaceutics. 2020;12(6)doi: 10.3390/pharmaceutics12060530.
Franzè, S., Selmin, F., Rocco, P., Colombo, G., Casiraghi, A., & Cilurzo, F. (2020). Preserving the Integrity of Liposomes Prepared by Ethanol Injection upon Freeze-Drying: Insights from Combined Molecular Dynamics Simulations and Experimental Data. Pharmaceutics, 12(6), . https://doi.org/10.3390/pharmaceutics12060530
Franzè, Silvia, et al. "Preserving the Integrity of Liposomes Prepared by Ethanol Injection upon Freeze-Drying: Insights from Combined Molecular Dynamics Simulations and Experimental Data." Pharmaceutics vol. 12,6 (2020). doi: https://doi.org/10.3390/pharmaceutics12060530
Franzè S, Selmin F, Rocco P, Colombo G, Casiraghi A, Cilurzo F. Preserving the Integrity of Liposomes Prepared by Ethanol Injection upon Freeze-Drying: Insights from Combined Molecular Dynamics Simulations and Experimental Data. Pharmaceutics. 2020 Jun 09;12(6). doi: 10.3390/pharmaceutics12060530. PMID: 32526935; PMCID: PMC7356173.
Copy Download .nbib Format: NLM
Nexavar(®)-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012.

Journal of pharmacology & pharmacotherapeutics

Cilurzo F, Staltari O, Patanè M, Ammendola M, Garaffo C, Di Paola ED.
PMID: 24347990
J Pharmacol Pharmacother. 2013 Dec;4:S86-9. doi: 10.4103/0976-500X.120971.

Hepatocellular carcinoma (HCC) remains a major global health problem and Calabria in the south of Italy is not an exception. Sorafenib is the first and only Food and Drug Administration approved drug for the treatment of advanced HCC and...

Cite
Cilurzo F, Staltari O, Patanè M, et al. Nexavar(®)-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012. J Pharmacol Pharmacother. 2013;4:S86-9doi: 10.4103/0976-500X.120971.
Cilurzo, F., Staltari, O., Patanè, M., Ammendola, M., Garaffo, C., & Di Paola, E. D. (2013). Nexavar(®)-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012. Journal of pharmacology & pharmacotherapeutics, 4S86-9. https://doi.org/10.4103/0976-500X.120971
Cilurzo, Felisa, et al. "Nexavar(®)-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012." Journal of pharmacology & pharmacotherapeutics vol. 4 (2013): S86-9. doi: https://doi.org/10.4103/0976-500X.120971
Cilurzo F, Staltari O, Patanè M, Ammendola M, Garaffo C, Di Paola ED. Nexavar(®)-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012. J Pharmacol Pharmacother. 2013 Dec;4:S86-9. doi: 10.4103/0976-500X.120971. PMID: 24347990; PMCID: PMC3853677.
Copy Download .nbib Format: NLM
Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds.

Stem cells international

Hafeez MN, d'Avanzo N, Russo V, Di Marzio L, Cilurzo F, Paolino D, Fresta M, Barboni B, Santos HA, Celia C.
PMID: 34824586
Stem Cells Int. 2021 Nov 16;2021:1488829. doi: 10.1155/2021/1488829. eCollection 2021.

The natural healing capacity of the tendon tissue is limited due to the hypovascular and cellular nature of this tissue. So far, several conventional approaches have been tested for tendon repair to accelerate the healing process, but all these...

Cite
Hafeez MN, d'Avanzo N, Russo V, et al. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds. Stem Cells Int. 2021;2021:1488829doi: 10.1155/2021/1488829.
Hafeez, M. N., d'Avanzo, N., Russo, V., Di Marzio, L., Cilurzo, F., Paolino, D., Fresta, M., Barboni, B., Santos, H. A., & Celia, C. (2021). Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds. Stem cells international, 20211488829. https://doi.org/10.1155/2021/1488829
Hafeez, Muhammad Nadeem, et al. "Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds." Stem cells international vol. 2021 (2021): 1488829. doi: https://doi.org/10.1155/2021/1488829
Hafeez MN, d'Avanzo N, Russo V, Di Marzio L, Cilurzo F, Paolino D, Fresta M, Barboni B, Santos HA, Celia C. Tendon Tissue Repair in Prospective of Drug Delivery, Regenerative Medicines, and Innovative Bioscaffolds. Stem Cells Int. 2021 Nov 16;2021:1488829. doi: 10.1155/2021/1488829. eCollection 2021. PMID: 34824586; PMCID: PMC8610661.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 27 entries